FR2449093A1 - Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments - Google Patents

Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments

Info

Publication number
FR2449093A1
FR2449093A1 FR8003143A FR8003143A FR2449093A1 FR 2449093 A1 FR2449093 A1 FR 2449093A1 FR 8003143 A FR8003143 A FR 8003143A FR 8003143 A FR8003143 A FR 8003143A FR 2449093 A1 FR2449093 A1 FR 2449093A1
Authority
FR
France
Prior art keywords
preparation
group
cephalosporin derivatives
medicaments
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8003143A
Other languages
English (en)
French (fr)
Other versions
FR2449093B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2449093A1 publication Critical patent/FR2449093A1/fr
Application granted granted Critical
Publication of FR2449093B1 publication Critical patent/FR2449093B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8003143A 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments Granted FR2449093A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them

Publications (2)

Publication Number Publication Date
FR2449093A1 true FR2449093A1 (fr) 1980-09-12
FR2449093B1 FR2449093B1 (en:Method) 1983-07-29

Family

ID=25683752

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8003143A Granted FR2449093A1 (fr) 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments

Country Status (19)

Country Link
US (1) US4477448A (en:Method)
AT (1) AT374806B (en:Method)
CA (1) CA1161032A (en:Method)
DE (1) DE3005012A1 (en:Method)
DK (1) DK53780A (en:Method)
ES (2) ES8102134A1 (en:Method)
FI (1) FI800381A7 (en:Method)
FR (1) FR2449093A1 (en:Method)
GB (2) GB2046734B (en:Method)
IE (1) IE49395B1 (en:Method)
IL (1) IL59391A (en:Method)
IT (1) IT8047922A0 (en:Method)
MY (1) MY8500128A (en:Method)
NL (1) NL8000894A (en:Method)
NZ (1) NZ192873A (en:Method)
PH (1) PH17926A (en:Method)
PT (1) PT70834A (en:Method)
SE (2) SE8000982L (en:Method)
YU (1) YU40280A (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498189A1 (fr) * 1981-01-19 1982-07-23 Sandoz Sa Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments
FR2530635A1 (fr) * 1982-07-23 1984-01-27 Servipharm Ltd Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165922D1 (en) * 1980-03-28 1984-10-18 Biochemie Gmbh New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
DE60011646T2 (de) * 1999-09-24 2005-06-23 Agro-Kanesho Co., Ltd. Insektizide und akarizide
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498189A1 (fr) * 1981-01-19 1982-07-23 Sandoz Sa Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments
FR2501685A1 (fr) * 1981-01-19 1982-09-17 Sandoz Sa Nouveaux derives du pyrazole
FR2530635A1 (fr) * 1982-07-23 1984-01-27 Servipharm Ltd Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres

Also Published As

Publication number Publication date
US4477448A (en) 1984-10-16
ES488651A0 (es) 1980-12-16
IE49395B1 (en) 1985-10-02
DK53780A (da) 1980-08-17
GB8309730D0 (en) 1983-05-18
DE3005012A1 (de) 1980-11-27
ES8102134A1 (es) 1980-12-16
GB2117774A (en) 1983-10-19
IL59391A0 (en) 1980-05-30
GB2046734B (en) 1983-09-01
IL59391A (en) 1983-05-15
GB2046734A (en) 1980-11-19
NZ192873A (en) 1984-07-31
SE8500589D0 (sv) 1985-02-08
YU40280A (en) 1983-06-30
ES8203848A1 (es) 1982-04-01
CA1161032A (en) 1984-01-24
FI800381A7 (fi) 1981-01-01
PH17926A (en) 1985-01-31
IE800284L (en) 1980-08-16
FR2449093B1 (en:Method) 1983-07-29
IT8047922A0 (it) 1980-02-15
SE8000982L (sv) 1980-08-17
PT70834A (en) 1980-03-01
ATA78780A (de) 1983-10-15
NL8000894A (nl) 1980-08-19
ES497002A0 (es) 1982-04-01
GB2117774B (en) 1984-03-21
AT374806B (de) 1984-06-12
MY8500128A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
FR2377374A1 (fr) Derives acyles d'amino-acides et leur utilisation comme medicaments
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2439182A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2314731A1 (fr) Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE843140A (fr) Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE868796A (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2370753A1 (fr) Derives du glucofurannose et leur application therapeutique
FR2392991A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
FR2336133A1 (fr) Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments
FR2456104A1 (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
BE877658A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2335222A1 (fr) Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant
BE878256A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2397418A1 (fr) Esters de penicilline utilisables comme medicaments et procede pour leur preparation
FR2336134A1 (fr) Derives trifluoromethylthio de cyproheptadine utiles comme medicament
IE790754L (en) Substituted ethanolamines
FR2368490A1 (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant
BE863802A (fr) Nouveaux derives d'everninomicine, leur procedes de preparation et compositions pharmaceutiques contenant lesdits derives
BE863843A (fr) Nouveaux derives d'acides benzo-heterocyclylglyoxyliques, leur preparation et leur application en tant que medicaments
BE849177A (fr) Derives thiadiazolyliques de l'acide 7-acylamido-3-cepheme-4-carboxylique et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse